Hiroko Oshima
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 15
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 8
- Oncology top 1%
- Cancer Cells and Metastasis 12
- Cancer-related Molecular Pathways 6
- Molecular Biology top 2%
- Cancer-related gene regulation 8
- Genetics top 1%
-
- Helicobacter pylori-related gastroenterology studies 22
-
- Genetic factors in colorectal cancer 14
-
- Cancer, Stress, Anesthesia, and Immune Response 6
- Co-authors
- Masanobu OshimaMakoto M. TaketoStacia KargmanJoseph DinchukElizabeth KwongJames M. TrzăskosBruno C. HancockJilly F. Evans
- Cited by
- PharmacologyCancer ResearchOncology
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Hiroko Oshima
83 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Pharmacology 2.2k
- Cancer Research 1.7k
- Oncology 2.2k
- Molecular Biology 4.0k
- Genetics 1.6k
Countries citing papers authored by Hiroko Oshima
This map shows the geographic impact of Hiroko Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Oshima more than expected).
Fields of papers citing papers by Hiroko Oshima
This network shows the impact of papers produced by Hiroko Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Oshima. The network helps show where Hiroko Oshima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroko Oshima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 46 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 19 | |
| 6 | 2019 | 59 | |
| 7 | 2018 | 39 | |
| 8 | 2018 | 45 | |
| 9 | 2018 | 27 | |
| 10 | 2017 | 66 | |
| 11 | 2017 | 8 | |
| 12 | 2016 | 22 | |
| 13 | 2015 | 14 | |
| 14 | 2015 | 78 | |
| 15 | 2009 | 25 | |
| 16 | Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer | 2009 | 145 |
| 17 | 2009 | 114 | |
| 18 | 2008 | 0 | |
| 19 | 2005 | 258 | |
| 20 | TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesisbreakdown → | 1996 | 540 |
About Hiroko Oshima
Hiroko Oshima is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 87 papers that have together received 8.2k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (22 papers), Inflammatory mediators and NSAID effects (15 papers), Genetic factors in colorectal cancer (14 papers), Cancer Cells and Metastasis (12 papers), Cancer-related gene regulation (8 papers), Cancer Genomics and Diagnostics (8 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Pharmacology (2.2k citations), Cancer Research (1.7k citations) and Oncology (2.2k citations). Hiroko Oshima has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Masanobu Oshima, Makoto M. Taketo, Stacia Kargman, Joseph Dinchuk, Elizabeth Kwong, James M. Trzăskos, Bruno C. Hancock, Jilly F. Evans, Masahiko Kobayashi and Kazuaki Takaku. Their work appears in journals such as Cancer Research, Cancer Science, Oncogene, Gastroenterology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.